4.5 Article

Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation

Kathrin Meyer et al.

HUMAN MOLECULAR GENETICS (2009)

Article Biochemistry & Molecular Biology

DcpS as a Therapeutic Target for Spinal Muscular Atrophy

Jasbir Singh et al.

ACS CHEMICAL BIOLOGY (2008)

Article Clinical Neurology

Sustained Improvement of Spinal Muscular Atrophy Mice Treated with Trichostatin A Plus Nutrition

Heather L. Narver et al.

ANNALS OF NEUROLOGY (2008)

Article Biochemistry & Molecular Biology

Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy

Shingo Kariya et al.

HUMAN MOLECULAR GENETICS (2008)

Article Clinical Neurology

The effect of hydroxyurea in spinal muscular atrophy cells and patients

Wen-Chen Liang et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)

Article Multidisciplinary Sciences

Modeling Spinal Muscular Atrophy in Drosophila

Howard Chia-Hao Chang et al.

PLOS ONE (2008)

Editorial Material Biochemistry & Molecular Biology

DcpS, a general modulator of cap-binding protein-dependent processes?

Sophie Bail et al.

RNA BIOLOGY (2008)

Article Biochemistry & Molecular Biology

Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing

Tatyana Novoyatleva et al.

HUMAN MOLECULAR GENETICS (2008)

Article Genetics & Heredity

Induction of full-length survival motor neuron by polyphenol botanical compounds

Mary S. Sakla et al.

HUMAN GENETICS (2008)

Article Multidisciplinary Sciences

A small-molecule therapeutic lead for Huntington's disease: Preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouse

Vanita Chopra et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Neurosciences

Abnormal motor phenotype in the SMNΔ7 mouse model of spinal muscular atrophy

Matthew E. R. Butchbach et al.

NEUROBIOLOGY OF DISEASE (2007)

Article Biochemical Research Methods

A novel method for oral delivery of drug compounds to the neonatal SMNΔ7 mouse model of spinal muscular atrophy

Matthew E. R. Butchbach et al.

JOURNAL OF NEUROSCIENCE METHODS (2007)

Article Medicine, Research & Experimental

Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy

Amy M. Avila et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Genetics & Heredity

Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts

Virginia B. Mattis et al.

HUMAN GENETICS (2006)

Article Genetics & Heredity

A feasibility study for the newborn screening of spinal muscular atrophy

Robert E. Pyatt et al.

GENETICS IN MEDICINE (2006)

Article Clinical Neurology

Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells

SM Grzeschik et al.

ANNALS OF NEUROLOGY (2005)

Article Biochemistry & Molecular Biology

The activity of the spinal muscular atrophy protein is regulated during development and cellular differentiation

F Gabanella et al.

HUMAN MOLECULAR GENETICS (2005)

Article Multidisciplinary Sciences

A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo

XQ Zhang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Biochemistry & Molecular Biology

Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism

MR Lunn et al.

CHEMISTRY & BIOLOGY (2004)

Article Biochemistry & Molecular Biology

Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy

C Andreassi et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2004)

Article Biochemistry & Molecular Biology

Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy

L Brichta et al.

HUMAN MOLECULAR GENETICS (2003)

Article Biochemistry & Molecular Biology

Neuromuscular defects in a Drosophila survival motor neuron gene mutant

YB Chan et al.

HUMAN MOLECULAR GENETICS (2003)

Article Clinical Neurology

Valproic acid increases SMN levels in spinal muscular atrophy patient cells

CJ Sumner et al.

ANNALS OF NEUROLOGY (2003)

Article Biochemistry & Molecular Biology

Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model

C Cifuentes-Diaz et al.

HUMAN MOLECULAR GENETICS (2002)

Review Biotechnology & Applied Microbiology

Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer

RW Johnstone

NATURE REVIEWS DRUG DISCOVERY (2002)

Article Biochemistry & Molecular Biology

Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients

C Andreassi et al.

HUMAN MOLECULAR GENETICS (2001)

Article Multidisciplinary Sciences

Treatment of spinal muscular atrophy by sodium butyrate

JG Chang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Genetics & Heredity

A mouse model for spinal muscular atrophy

HM Hsieh-Li et al.

NATURE GENETICS (2000)